High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer

Human Pathology

Volumn 43, Issue 9, 2012, Pages 1471-1481

  Stenzinger, Albrecht ^a   Wittschieber, Daniel ^b   Von Winterfeld, Moritz ^c   Goeppert, Benjamin ^a   Kamphues, Carsten ^c   Weichert, Wilko ^a   Dietel, Manfred ^c   Rabien, Anja ^c   Klauschen, Frederick ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Biomarker; CD147; Colorectal cancer; EMMPRIN; Prognosis; Prognosticator

Indexed keywords

CD147 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ASCENDING COLON; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; DESCENDING COLON; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; SURVIVAL TIME; TISSUE MICROARRAY; TRANSVERSE COLON;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD147; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS;

EID: 84864284352     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.10.023     Document Type: Article

References (35)

1. P. Boyle, and M.E. Leon Epidemiology of colorectal cancer Br Med Bull 64 2002 1 25 (Pubitemid 35238576)
2. A.B. Benson III Epidemiology, disease progression, and economic burden of colorectal cancer J Manag Care Pharm 13 6 Suppl C 2007 S5 S18
3. T.P. Pretlow, B.J. Barrow, and W.S. Ashton Aberrant crypts: putative preneoplastic foci in human colonic mucosa Cancer Res 51 1991 1564 1567
4. S. Hiraoka, J. Kato, and S. Fujiki The presence of large serrated polyps increases risk for colorectal cancer Gastroenterology 139 2010 1503 1510
5. A.E. Noffsinger Serrated polyps and colorectal cancer: new pathway to malignancy Annu Rev Pathol 4 2009 343 364
6. L.H. Sobin, M.K. Gospodarowicz, and Ch. Wittekind TNM classification of malignant tumours. UICC International Union Against Cancer 7th ed. 2009 Wiley-Blackwell Oxford
7. S.L. Parker, T. Tong, S. Bolden, and P.A. Wingo Cancer statistics, 1997 CA Cancer J Clin 47 1997 5 27 (Pubitemid 27050847)
8. E. Vakiani, and D.B. Solit KRAS and BRAF: drug targets and predictive biomarkers J Pathol 223 2011 219 229
9. W. De Roock, B. Biesmans, J. De Schutter, and S. Tejpar Clinical biomarkers in oncology: focus on colorectal cancer Mol Diagn Ther 13 2009 103 114
10. X.L. Yu, T. Hu, and J.M. Du Crystal structure of HAb18G/CD147: implications for immunoglobulin superfamily homophilic adhesion J Biol Chem 283 2008 18056 18065
11. J. Luo, A. Teplyakov, and G. Obmolova Structure of the EMMPRIN N-terminal domain 1: dimerization via beta-strand swapping Proteins 77 2009 1009 1014
12. E.E. Gabison, E. Huet, C. Baudouin, and S. Menashi Direct epithelial-stromal interaction in corneal wound healing: role of EMMPRIN/CD147 in MMPs induction and beyond Prog Retin Eye Res 28 2009 19 33
13. E.E. Gabison, T. Hoang-Xuan, A. Mauviel, and S. Menashi EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair Biochimie 87 2005 361 368 (Pubitemid 40387615)
14. T. Renno, A. Wilson, and C. Dunkel A role for CD147 in thymic development J Immunol 168 2002 4946 4950 (Pubitemid 34495956)
15. R. DeCastro, Y. Zhang, and H. Guo Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer J Invest Dermatol 106 1996 1260 1265 (Pubitemid 26195850)
16. W. Sienel, B. Polzer, and K. Elshawi Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9 Mod Pathol 21 2008 1130 1138
17. A.B. Als, L. Dyrskjot, and H. von der Maase Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer Clin Cancer Res 13 15 Pt 1 2007 4407 4414 (Pubitemid 47219707)
18. D. Wittschieber, A. Stenzinger, and F. Klauschen Decreased RECK and increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness Pathobiology 78 2011 123 131
19. S. Riethdorf, N. Reimers, and V. Assmann High incidence of EMMPRIN expression in human tumors Int J Cancer 119 2006 1800 1810 (Pubitemid 44356836)
20. Z.D. Han, H.C. He, and X.C. Bi Expression and clinical significance of CD147 in genitourinary carcinomas J Surg Res 160 2010 260 267
21. K. Nabeshima, H. Iwasaki, K. Koga, H. Hojo, J. Suzumiya, and M. Kikuchi Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression Pathol Int 56 2006 359 367 (Pubitemid 43886799)
22. S.S. Sidhu, A.T. Mengistab, A.N. Tauscher, J. LaVail, and C. Basbaum The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions Oncogene 23 2004 956 963 (Pubitemid 38250941)
23. C. Biswas, Y. Zhang, and R. DeCastro The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily Cancer Res 55 1995 434 439
24. H. Guo, G. Majmudar, T.C. Jensen, C. Biswas, B.P. Toole, and M.K. Gordon Characterization of the gene for human EMMPRIN, a tumor cell surface inducer of matrix metalloproteinases Gene 220 1998 99 108 (Pubitemid 28470328)
25. Y. Tang, M.T. Nakada, and P. Kesavan Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases Cancer Res. 65 2005 3193 3199 (Pubitemid 40524601)
26. S.S. Sidhu, R. Nawroth, M. Retz, H. Lemjabbar-Alaoui, V. Dasari, and C. Basbaum EMMPRIN regulates the canonical Wnt/beta-catenin signaling pathway, a potential role in accelerating lung tumorigenesis Oncogene 29 2010 4145 4156
27. W. Remmele, and H.E. Stegner Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologe 8 1987 138 140
28. D. Schrag The price tag on progress - chemotherapy for colorectal cancer N Engl J Med 351 2004 317 319 (Pubitemid 38944397)
29. S. Ramaswamy, K.N. Ross, E.S. Lander, and T.R. Golub A molecular signature of metastasis in primary solid tumors Nat Genet 33 2003 49 54 (Pubitemid 36068681)
30. M.F. van der Jagt, T. Wobbes, L.J. Strobbe, F.C. Sweep, and P.N. Span Metalloproteinases and their regulators in colorectal cancer J Surg Oncol 101 2010 259 269
31. Q. Zhou, Y. Zhu, Z. Deng, H. Long, S. Zhang, and X. Chen VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma Surg Oncol 20 2011 13 19
32. H.C. Zheng, W. Wang, and X.Y. Xu Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level J Cancer Res Clin Oncol 137 2011 585 596
33. M.F. van der Jagt, F.C. Sweep, and E.T. Waas Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer Cancer Lett 237 2006 289 297 (Pubitemid 43777076)
34. D. Buergy, T. Fuchs, and P. Kambakamba Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer Cancer 115 2009 4667 4678
35. S. Boulos, B.P. Meloni, P.G. Arthur, B. Majda, C. Bojarski, and N.W. Knuckey Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury Neurobiol Dis 25 2007 54 64 (Pubitemid 44765217)